Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.
about
Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomographyInterface between tauopathies and synucleinopathies: A tale of two proteinsGenome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson diseaseClinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: a case reportArgyrophilic grains: a distinct disease or an additive pathology?Neuropathology of non-Alzheimer degenerative disordersTSPO imaging in parkinsonian disordersCharacteristics of Tau and Its Ligands in PET ImagingGenetics Underlying Atypical Parkinsonism and Related Neurodegenerative DisordersTherapeutic and diagnostic challenges for frontotemporal dementiaClinicopathologic assessment and imaging of tauopathies in neurodegenerative dementiasThe first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathyThe corticobasal syndrome-Alzheimer's disease conundrumNeurofibrillary tangle-predominant dementia: comparison with classical Alzheimer diseaseValidation of the new consensus criteria for the diagnosis of corticobasal degenerationIdentification of common variants influencing risk of the tauopathy progressive supranuclear palsy.Frontotemporal Dementia.Signal alterations of the basal ganglia in the differential diagnosis of Parkinson's disease: a retrospective case-controlled MRI data bank analysis.Iron metabolism in Parkinsonian syndromes.Pedigree with frontotemporal lobar degeneration--motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9.Multiprotein deposits in neurodegenerative disorders: our experience in the tissue brain bank of Navarra.Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative DiseasesNeuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar DegenerationSeizures in corticobasal degeneration: a case report.Sporadic corticobasal syndrome due to FTLD-TDP.Quantitative neuropathology: an update on automated methodologies and implications for large scale cohorts.Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analysesAbnormal Resting-State Functional Connectivity in Progressive Supranuclear Palsy and Corticobasal Syndrome.Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes.A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition.Biomarkers in frontotemporal lobar degenerations--progress and challenges.Dopamine Transporter SPECT Imaging in Corticobasal Syndrome.Frontal white matter tracts sustaining speech production in primary progressive aphasiaTemporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis.An unusual cause of dementia: essential diagnostic elements of corticobasal degeneration-a case report and review of the literatureFrontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease.Visuoperception test predicts pathologic diagnosis of Alzheimer disease in corticobasal syndromeMultimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia.Symmetric corticobasal degeneration (S-CBD).
P2860
Q21146623-53579AB3-66DF-433F-BD0B-8ADD2B92B199Q22252940-2AC1A5A6-636A-4DD8-8415-1FDCAAB69FCEQ24596763-C2242772-01E2-4CD9-B214-5BF632F0EFD6Q24647584-CC1C7C59-10D5-4EF6-9FE0-142E505896C4Q24650928-E4481D1C-0200-4A6F-A4A7-AD497753B2FAQ24657571-EB7CCD37-4C4D-471F-B51B-4AF937BB5A90Q26747214-975BB454-281D-4C66-A801-4E7F1BE145AAQ26769952-61051553-F644-4EBE-919A-CA2202973CFDQ26779001-AC51AC3F-15D8-4665-BE75-169FA0514D33Q26998919-FDDF1217-E4F3-4053-930A-A8516E6B9341Q27003078-71FD350E-D8E6-4440-96A8-BB4626C13D27Q28085165-D4696AC1-01D3-41BE-939D-3D058C2EB3C4Q28250881-123DBDC5-7D51-4C62-9C5E-F086F588E481Q28272774-5573493D-CF8C-4539-8003-62BFFD069BD5Q28655239-205D9CD5-59B1-4AAE-A0CC-1226648027BCQ29417026-91813D54-F87C-4468-B7F3-21E54A8AEDE0Q30234793-D4DCDF8C-76CB-4E07-93FA-3681EB78996FQ30583514-45297118-02F1-4BFA-A86F-1AF413C00334Q33248678-2FD0157D-BFF2-4F69-AEA0-2850844B4075Q33364603-56C1BFA0-10AB-421E-B45A-D7A9623BFAEFQ33453702-9A60DDDD-4D36-4660-A547-5B979C364602Q33624586-CF5465EE-5FD1-4362-A4A7-C66AC97937C3Q33685317-64246A35-B22C-4CFF-B442-2EE1DC70BDBAQ33690332-505873C1-710F-43E8-B99B-C95A2C436CF9Q33703433-C5DA8535-7A8E-406F-BE76-AB8E3F590DCBQ33734079-DBA36A87-243E-4A97-BDC7-175696E29470Q33765800-6B4EFF41-4092-4249-80FC-262E1D9AC71BQ33766237-4C92BE07-4A66-4784-A801-BCF4071904A3Q33806930-53A18905-4763-4810-8699-1D962DFCE6BFQ33808422-00E328C5-5765-4BF9-8241-0712AC4B74CAQ33893515-458E7D78-4467-494C-AED2-6922F9798A43Q33894779-450A2392-26CD-45E1-AFB9-E4E72E2ACA55Q33906635-3339BB35-9C8C-4658-B51F-59B2A4E7F74EQ33926731-EC6116DC-7890-4CF7-96D5-988B38CA19FCQ33970004-9559DFCA-7482-4518-B727-DD540FE20163Q34046590-CAB3CB55-7EA0-4FC0-AEA2-42804989BAA4Q34066242-86B25F63-A83C-4B33-AB9B-5A1095776AC2Q34079332-CEAF8538-F3DF-44BB-B147-0B339E3ADD23Q34099180-7DFF4190-CF31-4E9D-9E93-D7F6DE58B391Q34136201-8F88E91E-F12B-4654-A475-D71A7AA0782D
P2860
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.
@en
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.
@nl
type
label
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.
@en
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.
@nl
prefLabel
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.
@en
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.
@nl
P2093
P2860
P356
P1476
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration
@en
P2093
C Bergeron
C Duyckaerts
D Horoupian
D W Dickson
J P Vonsattel
K Jellinger
K Wakabayashi
P2860
P304
P356
10.1093/JNEN/61.11.935
P50
P577
2002-11-01T00:00:00Z